Back to VIKING GLOBAL INVESTORS LP VIKING GLOBAL INVESTORS LP

BMRNBMRN
Showing 8 of 26 quarters

Position history for VIKING GLOBAL INVESTORS LPVIKING GLOBAL INVESTORS LP's holdings in BIOMARIN PHARMACEUTICAL INC

VIKING GLOBAL INVESTORS LP holds 7.6M shares of BMRN (BIOMARIN PHARMACEUTICAL INC), worth $435.8M as of 2026-Q2. The position was increased (+7.8% shares). BMRN represents 1.2% of VIKING GLOBAL INVESTORS LP's portfolio.

Current Value

$435.8M

Current Shares

7.6M

Total Value Change

-$249.7M

Total Shares Change

-2.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
7.6M
+7.8%
$435.8M1.2%$57.22
53
2026-Q1
Increased
7.1M
+17.0%
$398.9M1.1%$56.49
57
2025-Q4
Decreased
6M
-27.5%
$358.8M1.0%$59.43
0
2025-Q3
Decreased
8.3M
-32.3%
$450.7M1.2%$54.16
0
2025-Q2
Increased
12.3M
+13.8%
$675.5M2.0%$54.97
57
2025-Q1
Increased
10.8M
+2.8%
$763.5M2.4%$70.69
56
2024-Q4
Increased
10.5M
+7.8%
$690.9M2.2%$65.73
59
2024-Q3
Increased
9.8M
+38.1%
$685.6M2.5%$70.29
71

Other major holders of BMRN: BNP PARIBAS FINANCIAL MARKETS, Capital Research Global Investors, PRIMECAP MANAGEMENT CO/CA/, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used